INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-2 AND PROTEIN-3 STIMULATE GROWTH-HORMONE RECEPTOR-BINDING AND MITOGENESIS IN RAT OSTEOSARCOMA CELLS

被引:60
|
作者
SLOOTWEG, MC
OHLSSON, C
SALLES, JP
DEVRIES, CP
NETELENBOS, JC
机构
[1] FREE UNIV AMSTERDAM HOSP,RES INST ENDOCRINOL,1007 MB AMSTERDAM,NETHERLANDS
[2] SAHLGRENS UNIV HOSP,ENDOCRINOL & METAB RES CTR,S-41345 GOTHENBURG,SWEDEN
关键词
D O I
10.1210/en.136.10.4210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
GH exerts its biological actions an osteoblasts through a specific high affinity receptor expressed on these cells. GH receptor binding is positively modulated by a number of factors, including retinoic acid and dexamethasone, whereas fetal calf serum strongly decreases the binding. To identify responsible factors in serum, components of serum, the insulin-like growth factors (IGFs)-I and -II, and IGF binding proteins (IGFBPs)-2 and -3 were tested for a possible negative modulatory role. IGF-I and -II decreased [I-125]hGH binding at an optimal concentration of 30 ng/ml for IGF-I and 100 ng/ml IGF-II, reducing the binding to 51% and 55%, respectively, of control values. A stimulation of [I-125]hGH binding was observed with IGFBP-2 as well as IGFBP-3, inducing an increase to 148% and 151% of control binding at an optimal concentration of 3000 ng/ml for both peptides. The effects of all peptides were dependent on the incubation time, being significantly increased after 8 h of incubation and reaching the full effect thereafter. The effects were declined at 24 h compared with 16 h for IGFBP-2 and -3 but not for IGF-I and -II. Coincubation of the cells with TGF-I and -II and IGFBP-2 and -3 neutralized the effects of the factors alone. In conclusion, these results show that IGF-I and -II on the one hand and IGFBP-2 and -3 on the other hand exert opposite actions on [I-125]hGH binding, IGFBP-5 and -3 exerting probably an IGF-independent effect. Further, IGF-I and -II decreased GH receptor messenger RNA (mRNA) levels, as quantified by a solution hybridization ribonuclease protection assay, from 8.65 +/- 1.78 attomoles (amol)/mu g DNA (control) to 2.4 +/- 0.68 and 2.16 +/- 0.92 amol/mu g DNA, respectively. IGFBP-5 increased GH receptor mRNA levels from 5.26 +/- 1.17 (control) to 18.19 +/- 3.48. Incubation with IGFBP-3 did not result in stimulation of GH receptor mRNA levels (8.59 +/- 2.91 amol/mu g DNA). This shows that the mechanism of regulation of the GH receptor is, except for IGFBP-3, at least in part on the mRNA level. Lastly, IGFBP-2 and IGFBP-3 are mitogenic for UMR-106.01 rat osteosarcoma cells, inducing an increase in cell number to 125% and 142% of control cell counts after 48 h of incubation with 1000 ng/ml IGFBP-2 and -3, whereas IGF-I, IGF-II and Long R(3) IGF-I did not stimulate proliferation. IGFBP-2 and -3 potentiate hGH induced mitogenesis at low hGH concentrations of both factors, whereas at higher concentrations no such effect is observed. IGF-I and -II inhibit hGHs action. The physiological relevance of GH receptor modulation is a subject of investigation at the present time.
引用
收藏
页码:4210 / 4217
页数:8
相关论文
共 50 条
  • [31] Nuclear actions of insulin-like growth factor binding protein-3
    Baxter, Robert C.
    GENE, 2015, 569 (01) : 7 - 13
  • [32] TUMOR HYPOGLYCEMIA IS NOT DUE TO ABNORMAL BINDING OF INSULIN-LIKE GROWTH FACTOR-II PRECURSOR TO INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-2
    BACH, LA
    PERDUE, JF
    HUDGINS, WR
    RECHLER, MM
    CLINICAL RESEARCH, 1992, 40 (02): : A166 - A166
  • [33] ADJUVANT RECOMBINANT HUMAN GROWTH-HORMONE STIMULATES INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 SECRETION IN CRITICALLY ILL TRAUMA PATIENTS
    PETERSEN, SR
    JEEVANANDAM, M
    HOLADAY, NJ
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1995, 39 (02): : 295 - 302
  • [34] GENOMIC STRUCTURE AND REGULATION OF THE PROMOTER OF THE RAT INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-2 GENE
    KUTOH, E
    MARGOT, JB
    SCHWANDER, J
    MOLECULAR ENDOCRINOLOGY, 1993, 7 (09) : 1205 - 1216
  • [35] Insulin-like growth factor binding Protein-3 suppresses osteoblast differentiation via bone morphogenetic protein-2
    Eguchi, Kaori
    Akiba, Yosuke
    Akiba, Nami
    Nagasawa, Masako
    Cooper, Lyndon F.
    Uoshima, Katsumi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 507 (1-4) : 465 - 470
  • [36] Transferrin binds insulin-like growth factors and affects binding properties of insulin-like growth factor binding protein-3
    Storch, S
    Kübler, B
    Höning, S
    Ackmann, M
    Zapf, J
    Blum, W
    Braulke, T
    FEBS LETTERS, 2001, 509 (03) : 395 - 398
  • [37] Time dependent impact of perinatal hypoxia on growth hormone, insulin-like growth factor 1 and insulin-like growth factor binding protein-3
    Kartal, Omer
    Aydmoz, Secil
    Kartal, Ayse Tugba
    Kelestemur, Taha
    Caglayan, Ahmet Burak
    Beker, Mustafa Caglar
    Karademir, Ferhan
    Suleymanoglu, Selami
    Kul, Mustafa
    Yulug, Burak
    Kilic, Ertugrul
    METABOLIC BRAIN DISEASE, 2016, 31 (04) : 827 - 835
  • [38] Time dependent impact of perinatal hypoxia on growth hormone, insulin-like growth factor 1 and insulin-like growth factor binding protein-3
    Ömer Kartal
    Seçil Aydınöz
    Ayşe Tuğba Kartal
    Taha Kelestemur
    Ahmet Burak Caglayan
    Mustafa Caglar Beker
    Ferhan Karademir
    Selami Süleymanoğlu
    Mustafa Kul
    Burak Yulug
    Ertugrul Kilic
    Metabolic Brain Disease, 2016, 31 : 827 - 835
  • [39] High-affinity growth hormone binding protein, insulin-like growth factor I and insulin-like growth factor binding protein 3 in adults with growth hormone deficiency
    Roelen, CA
    Koppeschaar, HP
    deVries, WR
    Zelissen, PM
    Snel, YE
    Doerga, ME
    Thijssen, JH
    Blankenstein, RA
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 135 (01) : 82 - 86
  • [40] DEVELOPMENTAL EXPRESSION OF RAT INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-2 BY ASTROCYTIC GLIAL-CELLS IN CULTURE
    OLSON, JA
    SHIVERICK, KT
    OGILVIE, S
    BUHI, WC
    RAIZADA, MK
    ENDOCRINOLOGY, 1991, 129 (02) : 1066 - 1074